Trimedyne (TMED) Stock Chart & Stock Price History $25.24 +0.07 (+0.28%) As of 08/29/2025 05:20 PM Eastern Add Compare Share Share Chart Stock AnalysisChartBuy This Stock Trimedyne Stock Price Performance The Trimedyne (TMED) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 493.88%, with a year-to-date return of 493.88%. In the past month, the stock has increased 4.69%, reflecting recent market activity. As of the latest close, Trimedyne traded at $25.24 with a market cap of $10.10 million and volume of 5 shares. Five years ago, the stock traded at $4.25, representing a 493.88% increase over that period. At the time, it had a market cap of $510 thousand and a volume of 110 shares. Receive TMED Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.28%1 Month Performance+4.69%3 Month Performance+493.88%Year-To-Date Performance+493.88%1 Year Performance+493.88%5 Year Performance+493.88% TMED Stock Chart for Tuesday, September, 2, 2025 TMED Chart by TradingView Trimedyne Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/01/2025$25.24$25.24$25.24$25.245 shs$10.10 million08/29/2025$25.17$25.24+0.28%$25.24$25.245 shs$10.10 million08/28/2025$25.28$25.17-0.44%$25.17$25.171 shs$10.07 million08/27/2025$25.28$25.28$25.28$25.2859 shs$10.11 million08/26/2025$24.99$25.28+1.16%$25.28$25.2873 shs$10.11 million08/25/2025$25.43$24.99-1.73%$25.30$24.99467 shs$10.00 million08/22/2025$25.15$25.43+1.11%$25.56$25.432,091 shs$10.17 million08/21/2025$25.16$25.15-0.04%$25.28$25.151,104 shs$10.06 million08/20/2025$25.13$25.16+0.12%$25.16$25.054,227 shs$10.06 million08/19/2025$25.15$25.13-0.08%$25.17$25.12482 shs$10.05 million Get the Latest News and Ratings for TMED and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. 08/18/2025$25.19$25.15-0.16%$25.36$25.151,523 shs$10.06 million08/15/2025$24.70$25.19+1.98%$25.22$25.051,962 shs$10.08 million08/14/2025$24.58$24.70+0.49%$24.70$24.391,888 shs$9.88 million08/13/2025$24.05$24.58+2.20%$24.58$24.54322 shs$9.83 million08/12/2025$23.73$24.05+1.35%$24.05$23.941,375 shs$9.62 million08/11/2025$23.72$23.73+0.04%$23.98$23.73806 shs$9.49 million08/08/2025$23.61$23.72+0.47%$23.72$23.68236 shs$9.49 million08/07/2025$23.98$23.61-1.54%$23.61$23.46824 shs$9.44 million08/06/2025$24.41$23.98-1.76%$24.38$23.922,281 shs$9.59 million08/05/2025$24.43$24.41-0.08%$24.44$24.31454 shs$9.76 million08/04/2025$24.11$24.43+1.33%$24.43$24.143,342 shs$9.77 million08/01/2025$24.03$24.11+0.33%$24.11$23.91621 shs$9.64 million Related Companies Heyu Biological Technology Stock Chart NeurAxis Stock Chart Magna-Lab Stock Chart ViewRay Stock Chart Viveve Medical Stock Chart Aksys Stock Chart Electromed Stock Chart QT Imaging Stock Chart KORE Group Stock Chart PodcastOne Stock Chart Receive TMED Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:TMED) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredSell this, buy thatI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trimedyne, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trimedyne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMED Stock Alerts